Global Psychedelic Drugs Market (2021 Edition) – Analysis By Drug, Route of Administration, Distribution Channel, By Region, By Country: Market Insights, Pipeline Drugs and Forecast with Impact of Covid-19 (2021-2026)
Executive Summary The Covid-19 pandemic has restricted the movement of people, confining them in their homes, caused severe trauma and stress in the form of sadness and loneliness and has affected the mental health of individuals. As a result, in many countries, people are facing medical conditions like depression and anxiety. The psychedelic drugs market with major potential for treatment of mental illnesses is likely to see more demand and hence likely to attract major investments in the near future.
Global Psychedelic Drugs Market was valued at USD 3.8 billion in the year 2020. The Psychedelic Drugs market is growing rapidly due to the increasing prevalence of depression and other mental disorders worldwide. The need for handling environmental stress and enhanced and better quality of lifestyle is acting as a driver for the Psychedelic Drugs market. The treatment for psychedelic drugs dependency is expected to boost psychedelic market growth.
In addition, rising research and development activities in psychedelic therapeutics categories across the world have supported industrial development significantly. Companies are aggressively investing in R&D activities to develop novel psychedelic treatment molecules with minimal side effects associated with these products. This has further resulted in a strong platform for the further growth of the psychedelic drug industry during the forecast period.
The North America region dominates the psychedelic drugs market. In North America, growing awareness of mental health disorders such as depression and stress is expected to boost the psychedelic drug market growth. Social elements such as economic stress, the partition of family-oriented supporting structures, exacerbating environmental conditions are further estimated to accelerate market growth during forecast period.
Scope of the Report • The report presents the analysis of Psychedelic Drugs Market for the historical period of 2016-2020 and the forecast period of 2021-2026.
• The report analyses Psychedelic Drugs Market by Route of Administration (Oral, Intranasal, Intravenous, Others)
• The report further assesses the Psychedelic Drugs Market by Drug (Gamma-hydroxybutyrate, MDMA, Ketamine, Psilocybin, Others)
• The report further assesses the Psychedelic Drugs Market by Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)
• The Global Psychedelic Drugs has been analysed By Region (North America, Europe and Asia Pacific) and By Country (United States, Canada, Germany, France, Italy, Spain, United Kingdom, China, Japan, India)
• The key insights of the report have been presented through the frameworks of Major Mergers & Acquisitions and Product Launch. Also, the attractiveness of the market has been presented By Region, By Route of Administration, By Drug and By Distribution Channel. Additionally, trends, drivers and challenges of the industry has been analysed in the report.
• The companies analysed in the report include Johnson & Johnson, Pfizer, AbbVie Inc., Jazz Pharmaceuticals, NUMINUS WELLNESS INC WS, COMPASS Pathways PLC, Mindset Pharma, Mydecine Innovations Group, TRYP Therapeutics Inc, MindMed and Cybin Inc.
Key Target Audience
• Pharmaceutical Companies
• Biotechnology Companies
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Government and Research Organisations
Our reports have been used by over 10K customers, including:
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
241 pages •
By Asia Market Information & Development Company
• May 2021
China’s demand for Home Testing Products has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Healthcare Chatbots Market Report The healthcare chatbots market by revenue is expected to grow at a CAGR of 27.17% during the period 2020–2026. The healthcare industry is adopting chatbots to automate repetitive tasks and save costs...
The global enteral feeding formulas market was valued at USD 6,697.08 million in 2020, and it is expected to reach USD 10,069.30 million by 2026, registering a CAGR of 7%, during the forecast period. The outbreak of COVID-19 is expected to impact the enteral feeding formulas market, as good supportive care remains the cornerstone in...
Germany - Healthcare, Regulatory and Reimbursement Landscape
The analyst has released its latest report, "Germany - Healthcare, Regulatory and Reimbursement Landscape".The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape...
The global dementia drugs market was valued at approximately USD 12,736.06 million in 2020 and is expected to witness a revenue of USD 19,655.10 million in 2026, with a CAGR of 7.87% over the forecast period. The outbreak of the COVID-19 pandemic is expected to have a significant impact on the Dementia drugs market. According to a research...
274 pages •
By Asia Market Information & Development Company
• Jun 2021
China’s demand for Blood Products has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
The Micro coil Market was valued at US$ 836.30 million in 2021 and is projected to reach US$ 1,151.53 million by 2028; it is expected to grow at a CAGR of 4.7% from 2021 to 2028. The growth of the Micro coil market is mainly attributed to factors such as rising prevalence of cardiac aneurysm, and surging incidence of neurovascular diseases....
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Personalized Nutrition Market Report
The personalized nutrition market is expected to grow at a CAGR of over 16% during 2021-2026.
Increasing disposable income in the developing regions and fast integration of digital healthcare technologies...
Executive Summary The Global Injectable Drugs Market was valued at USD 414.88 Billion in the year 2020. Increasing prevalence of diseases such as diabetes, cancer and auto-immune disorders like rheumatoid arthritis and multiple sclerosis with an upsurge in the number of chronic diseases have driven the need for drug delivery...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.